SEC Form 4 · accession 0001645627-18-000011
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President
Period of report
Feb 16, 2018
Accepted (ET)
Feb 21, 2018 · 12:36 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 16, 2018 | P | 1,000 | $0.053 | A | 24,824,189 | D | |
| Common Stock | Feb 16, 2018 | P | 1,000 | $0.0543 | A | 24,825,189 | D | |
| Common Stock | Feb 16, 2018 | P | 1,000 | $0.05 | A | 24,826,189 | D | |
| Common Stock | Feb 16, 2018 | P | 1,000 | $0.0524 | A | 24,827,189 | D | |
| Common Stock | Feb 16, 2018 | P | 1,000 | $0.0524 | A | 24,828,189 | D | |
| Common Stock | Feb 20, 2018 | P | 1,000 | $0.0474 | A | 24,829,189 | D | |
| Common Stock | Feb 20, 2018 | P | 1,000 | $0.0515 | A | 24,830,189 | D | |
| Common Stock | Feb 20, 2018 | P | 1,000 | $0.051 | A | 24,831,189 | D |
Table II — derivative securities
No Table II lines on this filing.